galactosidase


Also found in: Dictionary, Encyclopedia, Wikipedia.

galactosidase

 [gah-lak″to-si´dās]
an enzyme that catalyzes the conversion of galactoside to galactose; it occurs in two forms: α-galactosidase (melibiase) and β-galactosidase (lactase).

galactosidase

/ga·lac·to·si·dase/ (-si´dās) an enzyme that catalyzes the cleavage of terminal galactose residues from a variety of substrates; several such enzymes exist, each specific for α- or β-linked sugars and further specific for substrates, e.g., lactase.

galactosidase

(gə-lăk′tō-sĭ-dās′, -dāz′, -lăk-tō′-)
n.
An enzyme that catalyzes the hydrolysis of a galactoside.

galactosidase

an enzyme that catalyzes the metabolism of galactosides.

galactosidase

the inducible enzyme that catalyses the hydrolysis of galactosides (see GLYCOSIDE formed from the reaction of GALACTOSE with alcohol.

galactosidase

an enzyme that catalyzes the conversion of galactoside to galactose; it occurs in two forms: α-galactosidase (melibiase) and β-galactosidase (lactase). In deficiency states gangliosides (galactose-containing cerebrosides) accumulate in tissues. See also GM1gangliosidosis.
References in periodicals archive ?
There is a clear trend that galactosidase activity increases due to sonification, improving the viability of probiotics.
Solomons et al(6) demonstrated that gastrointestinal symptoms improved in a dose-dependent fashion with 196, 391, and 737 galactosidase units of enzymatic activity.
380 promoter::lacZ vector can be injected into Drosophila embryos, and tissue specific expression of this construct can be detected by staining tissues with the [beta] galactosidase chromogenic substrate, X Gal.
T] Strains 3302398 and 4401054 were indole positive and bile resistant, and they had positive enzyme reactions for N-acetyl-[beta]-glucosaminidase, [alpha] galactosidase, and [beta]-galactosidase, as described for A.
The investigators identified and sequenced seven different genes that code for the galactose-removing enzyme--beta galactosidase.
They are interested in techniques which allow the splitting of lactose by means of galactosidase into two other sugars: glucose and galactose.
NYSE AMEX: IBIO) today announced the engagement of CBR International Corporation (CBR) for strategic regulatory and clinical services to advance iBio's Orphan Drug designated, plant-produced human alpha galactosidase A ("-Gal A") enzyme candidate for development as a therapeutic option for patients with Fabry disease.
The investigators sequenced and removed seven genes for the galactose-removing enzyme beta galactosidase.
NYSE AMEX:IBIO) today announced it has acquired Orphan Drug Designation for plant-produced human alpha galactosidase A ("-Gal A") and related property rights from an affiliate of Kentucky Bioprocessing LLC ("KBP") and has initiated a program, based on its iBioLaunch[TM] platform, to develop an improved version of the enzyme for therapy of Fabry disease.